Page last updated: 2024-08-21

fluorobenzenes and Ventricular Dysfunction, Left

fluorobenzenes has been researched along with Ventricular Dysfunction, Left in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (60.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ara, N; Iuchi, A; Miyoshi, H; Mizuguchi, Y; Nagase, N; Oishi, Y; Oki, T1
Badar, AA; Cleland, JG; Gardner, RS; Hawkins, NM; Jhund, PS; Kjekshus, J; McMurray, JJ; Perez-Moreno, AC; Petrie, MC; van Veldhuisen, DJ; Watkins, S; Wedel, H; Wikstrand, J; Wong, CM1
Capurso, A; Capurso, C; Colacicco, AM; D'Introno, A; Frisardi, V; Gadaleta, A; Panza, F; Santamato, A; Solfrizzi, V1
Chang, SA; Kim, DH; Kim, HK; Kim, YJ; Oh, BH; Park, YB; Sohn, DW1
Barros, IM; Kristensen, SD; Moura, LM; Pinto, FJ; Ramos, SF; Rocha-Gonçalves, F1
Bianchi, C; Canale, ML; Del Prato, S; Delle Donne, MG; Di Bello, V; Mariani, M; Miccoli, R; Nardi, C; Palagi, C; Penno, G; Talini, E1
Goldstein, S; Imai, M; Jiang, A; Rastogi, S; Sabbah, HN; Sharov, VG; Wang, M; ZacĂ , V1
Mascitelli, L; Pezzetta, F1
Rahimtoola, SH1
Chan, KL; Dumesnil, JG; Giannoccaro, PJ; Jassal, DS; Joyner, CD; Jue, J; Pandey, AS; Tam, JW; Teo, KK1

Reviews

1 review(s) available for fluorobenzenes and Ventricular Dysfunction, Left

ArticleYear
The year in valvular heart disease.
    Journal of the American College of Cardiology, 2008, Feb-19, Volume: 51, Issue:7

    Topics: Animals; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Arabidopsis Proteins; Bioprosthesis; Body Surface Area; Catheterization; Cholesterol, LDL; Coronary Disease; Disease Progression; Echocardiography, Three-Dimensional; Endocarditis, Bacterial; Fluorobenzenes; Heart Valve Diseases; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mitral Valve Insufficiency; Mitral Valve Stenosis; Odds Ratio; Practice Guidelines as Topic; Prosthesis Design; Prosthesis Fitting; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tomography, X-Ray Computed; Treatment Outcome; Tricuspid Valve Insufficiency; Ventricular Dysfunction, Left

2008

Trials

6 trial(s) available for fluorobenzenes and Ventricular Dysfunction, Left

ArticleYear
Influence of comorbid cardiovascular risk factors on left atrial-left ventricular interaction in asymptomatic patients: clinical application of two-dimensional speckle-tracking echocardiography.
    International heart journal, 2014, Volume: 55, Issue:2

    Topics: Aged; Atherosclerosis; Atrial Function, Left; Carotid Intima-Media Thickness; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Prospective Studies; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Ventricular Dysfunction, Left; Ventricular Function, Left

2014
Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
    European heart journal, 2014, Dec-21, Volume: 35, Issue:48

    Topics: Aged; Angina Pectoris; Female; Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Pyrimidines; Retrospective Studies; Rosuvastatin Calcium; Stroke Volume; Sulfonamides; Treatment Outcome; Ventricular Dysfunction, Left

2014
Persistent regional diastolic dysfunction after myocardial ischemia and the effect of statin treatment: assessment with two-dimensional radial strain rate.
    Echocardiography (Mount Kisco, N.Y.), 2010, Volume: 27, Issue:3

    Topics: Angina Pectoris, Variant; Atorvastatin; Diastole; Exercise Test; Female; Fluorobenzenes; Heart; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Ischemia; Pyrimidines; Pyrroles; Reference Standards; Rosuvastatin Calcium; Sulfonamides; Ultrasonography; Ventricular Dysfunction, Left

2010
Rosuvastatin slows the development of diastolic dysfunction in calcific aortic stenosis.
    The Journal of heart valve disease, 2012, Volume: 21, Issue:4

    Topics: Aged; Aged, 80 and over; Aortic Valve Stenosis; Calcinosis; Diastole; Disease Progression; Echocardiography; Female; Fluorobenzenes; Follow-Up Studies; Heart Failure, Diastolic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Ventricular Dysfunction, Left

2012
Early impairment of left ventricular function in hypercholesterolemia and its reversibility after short term treatment with rosuvastatin A preliminary echocardiographic study.
    Atherosclerosis, 2008, Volume: 197, Issue:1

    Topics: Adult; Blood Flow Velocity; Densitometry; Diastole; Echocardiography, Doppler, Color; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Middle Aged; Pilot Projects; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Systole; Ventricular Dysfunction, Left

2008
Clinical usefulness of tissue Doppler imaging in patients with mild to moderate aortic stenosis: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin study.
    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2008, Volume: 21, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aortic Valve Stenosis; Echocardiography, Doppler; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prognosis; Pyrimidines; Reproducibility of Results; Rosuvastatin Calcium; Sensitivity and Specificity; Sulfonamides; Treatment Outcome; Ventricular Dysfunction, Left; Young Adult

2008

Other Studies

3 other study(ies) available for fluorobenzenes and Ventricular Dysfunction, Left

ArticleYear
Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure.
    Journal of the American Geriatrics Society, 2008, Volume: 56, Issue:7

    Topics: Aged; Cholesterol; Coronary Disease; Dementia; Fluorobenzenes; Geriatrics; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides; Ventricular Dysfunction, Left

2008
Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure.
    Journal of the American College of Cardiology, 2007, Aug-07, Volume: 50, Issue:6

    Topics: Animals; Coronary Angiography; Dogs; Fluorobenzenes; Heart Failure; Hematopoietic Stem Cells; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase 2; Myocardium; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left; Ventricular Remodeling

2007
Does hypercholesterolemia impair left ventricular function?
    Atherosclerosis, 2008, Volume: 196, Issue:1

    Topics: Case-Control Studies; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Pyrimidines; Rosuvastatin Calcium; Selection Bias; Sulfonamides; Ventricular Dysfunction, Left

2008